PEI-LUNG CHENFann C.S.-J.SHYANG-RONG SHIHWEI-SHIUNG YANGTIEN-CHUN CHANG2020-06-012020-06-0120162213-8587https://www.scopus.com/inward/record.uri?eid=2-s2.0-84964770185&doi=10.1016%2fS2213-8587%2816%2930013-4&partnerID=40&md5=014ac7599980f89304f2ac4aa37d8c5chttps://scholars.lib.ntu.edu.tw/handle/123456789/495975[SDGs]SDG3antithyroid agent; HLA B38 antigen; HLA DRB1 antigen; antithyroid agent; agranulocytosis; allele; antithyroid drug induced agranulocytosis; antithyroid drug induced agranulocytosis; drug induced disease; European; France; genetic susceptibility; genome-wide association study; genotype; Germany; human; Note; personalized medicine; priority journal; single nucleotide polymorphism; Spain; Sweden; agranulocytosis; Graves disease; personalized medicine; Agranulocytosis; Antithyroid Agents; Graves Disease; Humans; Precision Medicinenote10.1016/S2213-8587(16)30013-4271578212-s2.0-84964770185